Neurology Clinical Trials Market By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Observational, Expanded Access), By Indication (Alzheimer’s Disease, Parkinson’s Disease, Epilepsy, Stroke, Multiple Sclerosis, Migraine, Others), By End-User (Pharmaceutical & Biotech Companies, Hospitals & Clinics, Contract Research Organizations (CROs), Academic & Research Institutes, Government & Non-profit Organizations, Others), Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles and Market Forecast, 2025–2035

---

Report Coverage:

By Phase

• Phase I
• Phase II
• Phase III
• Phase IV

By Study Design

• Interventional
• Observational
• Expanded Access

By Indication

• Alzheimer’s Disease
• Parkinson’s Disease
• Epilepsy
• Stroke
• Multiple Sclerosis
• Migraine
• Others

By End-User

• Pharmaceutical & Biotech Companies
• Hospitals & Clinics
• Contract Research Organizations (CROs)
• Academic & Research Institutes
• Government & Non-profit Organizations
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Novartis International AG
• Biogen Inc.
• F. Hoffmann-La Roche Ltd.
• Eli Lilly and Company
• AbbVie Inc.
• Sanofi S.A.
• Merck & Co., Inc.
• GlaxoSmithKline plc (GSK)
• AstraZeneca plc
• Eisai Co., Ltd.
• Teva Pharmaceutical Industries Ltd.
• Pfizer Inc.
• Bayer AG
• Johnson & Johnson Services, Inc.
• Takeda Pharmaceutical Company Limited.